This Pharma Dividend Has Been Raised Every Single Year for Over a Decade

Key PointsAbbVie has successfully navigated through a major patent cliff, enabling it to sustain a dividend growth streak for more than a decade..

• April 07, 2026 — 09:50 pm EDT Written byThomas NielforThe Motley Fool-> AbbVie has successfully navigated through a major patent cliff, enabling it to sustain a dividend growth streak for more than a decade
• Thanks to two strong product portfolios, AbbVie's underlying growth, dividend growth, and share price growth are likely to persist
• Poised for further strong growth, consider this stock a strong choice for "buy and hold" investors